← Open Payments lookup

LATOYA GIBSON: Open Payments

NPI 1841898038 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$494 in 29 payments from 13 companies in 2025. Trend: 2023 $196 · 2024 $441 · 2025 $494

Food & beverage: $494
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$98
Phathom Pharmaceuticals, Inc.5$75
AstraZeneca Pharmaceuticals LP3$51
Lundbeck LLC3$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$48
Corcept Therapeutics2$35
Lilly USA, LLC2$29
Bayer Healthcare Pharmaceuticals Inc.2$29
Tris Pharma Inc1$21
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: REXULTI, VOQUEZNA, FARXIGA, XIFAXAN, Korlym, MOUNJARO, Kerendia, Dyanavel XR.

Industry payments across SC — which companies pay providers there.